Noor Jawad, Chaudhry Ahtshamullah, Batool Saima, Noor Riwad, Fatima Ghulam
Internal Medicine, St. Dominic Hospital, Jackson, USA.
Pathology, Nishtar Medical University, Multan, PAK.
Cureus. 2023 Jun 25;15(6):e40948. doi: 10.7759/cureus.40948. eCollection 2023 Jun.
The global obesity pandemic has prompted efforts to search for novel intervention options, including maximizing the health benefits of certain gut microbes and their metabolic byproducts. Our increased understanding of gut microbiota can potentially lead to revolutionary advancements in weight management and general well-being. We studied the association between gut microbiota and obesity, as well as the possible benefits of probiotics, prebiotics, and synbiotics in the prevention and management of obesity in this review. We observed a relationship between the metabolism of nutrients, energy consumption, and gut flora. Numerous mechanisms, including the synthesis of short-chain fatty acids, hormone stimulation, and persistent low-grade inflammation, have been postulated to explain the role of gut bacteria in the etiology of obesity. It has been discovered that the diversity and composition of the intestinal microbiome vary in response to various forms of obesity therapy, which raises concerns about the potential impact of these changes on weight loss. According to research, probiotics, prebiotics, and synbiotics may alter the release of hormones, neurotransmitters, and inflammatory factors, thereby diminishing the stimuli of food consumption that lead to weight gain. More clinical research is required to determine the optimal probiotic, prebiotic, and synbiotic supplementation dosages, formulations, and regimens for long-term weight management and to determine how different gastrointestinal microbiome bacterial species may influence weight gain.
全球肥胖流行促使人们努力寻找新的干预方法,包括最大化某些肠道微生物及其代谢副产物的健康益处。我们对肠道微生物群的深入了解可能会在体重管理和总体健康方面带来革命性进展。在本综述中,我们研究了肠道微生物群与肥胖之间的关联,以及益生菌、益生元及合生元在肥胖预防和管理中的潜在益处。我们观察到营养物质代谢、能量消耗与肠道菌群之间存在关联。人们推测了多种机制,包括短链脂肪酸的合成、激素刺激和持续性低度炎症,以解释肠道细菌在肥胖病因中的作用。已发现肠道微生物组的多样性和组成会因各种肥胖治疗方式而有所不同,这引发了对这些变化对体重减轻潜在影响的担忧。研究表明,益生菌、益生元及合生元可能会改变激素、神经递质和炎症因子的释放,从而减少导致体重增加的食物摄入刺激。需要更多临床研究来确定用于长期体重管理的最佳益生菌、益生元及合生元补充剂量、配方和方案,并确定不同的胃肠道微生物组细菌种类如何影响体重增加。